Literature DB >> 12911849

Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Peter P Toth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12911849     DOI： 10.1007/s11883-003-0010-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  59 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.

Authors:  S Roosbeek; B Vanloo; N Duverger; H Caster; J Breyne; I De Beun; H Patel; J Vandekerckhove; C Shoulders; M Rosseneu; F Peelman
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

3.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

Review 4.  The effects of altered apolipoprotein A-I structure on plasma HDL concentration.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

5.  Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan.

Authors:  J H Wu; Y T Lee; H C Hsu; L L Hsieh
Journal:  Atherosclerosis       Date:  2001-12       Impact factor: 5.162

6.  Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis.

Authors:  C W Rittershaus; D P Miller; L J Thomas; M D Picard; C M Honan; C D Emmett; C L Pettey; H Adari; R A Hammond; D T Beattie; A D Callow; H C Marsh; U S Ryan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

7.  Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.

Authors:  M C Carr; A F Ayyobi; S J Murdoch; S S Deeb; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

8.  Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population.

Authors:  T P Bersot; G L Vega; S M Grundy; K E Palaoglu; P Atagündüz; S Ozbayrakçi; O Gökdemir; R W Mahley
Journal:  J Lipid Res       Date:  1999-03       Impact factor: 5.922

Review 9.  Hepatic lipase: a pro- or anti-atherogenic protein?

Authors:  Hans Jansen; Adrie J M Verhoeven; Eric J G Sijbrands
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

10.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272
View more
  17 in total

Review 1.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

2.  Therapeutic reduction of coronary atheromatous plaque burden using bioengineered apoA-I Milano.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 3.  When high is low: raising low levels of high-density lipoprotein cholesterol.

Authors:  Peter P Toth
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 4.  Pharmacomodulation of high-density lipoprotein metabolism as a therapeutic intervention for atherosclerotic disease.

Authors:  Peter P Toth
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

5.  Relationship of maximal aerobic capacity with predictors of cardiovascular diseases in North Indian cardiac patients.

Authors:  Shweta Shenoy; Surbhi Suresh Wagle; Jaspal Singh Sandhu; H P Singh
Journal:  Heart Asia       Date:  2012-01-01

6.  Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.

Authors:  Chieh-Shou Su; Kuan-Ju Chen; Wayne Huey-Herng Sheu; Ya-Ling Yang; Tsun-Jui Liu; Wei-Chun Chang; Kuo-Yang Wang; Wen-Lieng Lee
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

7.  Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.

Authors:  A K Gupta; S R Smith; F L Greenway; G A Bray
Journal:  Diabetes Obes Metab       Date:  2009-04       Impact factor: 6.577

8.  Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.

Authors:  Harmen Wiersma; Alberto Gatti; Niels Nijstad; Folkert Kuipers; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2009-02-28       Impact factor: 5.922

9.  The Susceptibility to Diet-Induced Atherosclerosis Is Exacerbated with Aging in C57B1/6 Mice.

Authors:  Olivier Kamtchueng Simo; Hicham Berrougui; Tamas Fulop; Abdelouahed Khalil
Journal:  Biomedicines       Date:  2021-04-29

Review 10.  Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib.

Authors:  Marta A Miyares; Kyle Davis
Journal:  Vasc Health Risk Manag       Date:  2012-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.